VIMIAN GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.4 SEK | +2.26% |
|
-3.29% | -0.68% |
| Mar. 28 | Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss | DJ |
| Mar. 19 | Nordic Stocks Decreased Tuesday; Autostore Holdings Posted Biggest Loss | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.512
EUR
Average target price
3.344
EUR
Spread / Average Target
+33.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.68% | 1.4B | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -2.92% | 3.12B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -14.67% | 1.12B | |
| -5.37% | 990M | |
| -24.06% | 805M |
- Stock Market
- Equities
- VIMIAN Stock
- News Vimian Group AB
- Vimian Group to Launch SEK1.63 Billion Rights Issue for Acquisition Ventures
